Your browser doesn't support javascript.
loading
CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects.
Glez-Vaz, Javier; Azpilikueta, Arantza; Ochoa, María C; Olivera, Irene; Gomis, Gabriel; Cirella, Asunta; Luri-Rey, Carlos; Álvarez, Maite; Pérez-Gracia, Jose L; Ciordia, Sergio; Eguren-Santamaria, Iñaki; Alexandru, Raluca; Berraondo, Pedro; de Andrea, Carlos; Teijeira, Álvaro; Corrales, Fernando; Zapata, Juan M; Melero, Ignacio.
Afiliação
  • Glez-Vaz J; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
  • Azpilikueta A; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.
  • Ochoa MC; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
  • Olivera I; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.
  • Gomis G; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
  • Cirella A; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.
  • Luri-Rey C; Departments of Immunology-Immunotherapy, Pathology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain.
  • Álvarez M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Pérez-Gracia JL; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
  • Ciordia S; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.
  • Eguren-Santamaria I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
  • Alexandru R; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
  • Berraondo P; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.
  • de Andrea C; Departments of Immunology-Immunotherapy, Pathology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain.
  • Teijeira Á; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
  • Corrales F; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.
  • Zapata JM; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
  • Melero I; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.
Sci Adv ; 9(33): eadf6692, 2023 08 18.
Article em En | MEDLINE | ID: mdl-37595047
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Sci Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Sci Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha